CD28 incorporation into the anti-CD19 CAR structure promotes effector memory maturation, glycolysis, rapid tumor eradication, and T cell exhaustion, whereas 4-1BB signaling induces mitochondrial biogenesis, in vivo T cell persistence, and reprogramming towards a central memory T cell phenotype [6]. This evidence concerns the gene CD28 and neoplasm.